St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Epithelioid hemangioendothelioma (EHE) is a rare type of vascular tumor that affects the cells that line the inside of blood vessels (the vascular system). These cells are called epithelial cells. EHE tumors can appear in blood vessels anywhere in the body. They usually affect the soft tissues, liver, lungs, and bones. The cause of EHE is not known.
Vascular tumors like EHE are uncommon. They represent about 2% of soft tissue tumors in children and teens.
These tumors are cancerous. How fast they grow and how they affect the person vary widely between patients. Some people can live with these tumors for years with only minor symptoms that affect daily life. Sometimes the tumors even go away on their own. Other tumors can grow and spread quickly.
EHE symptoms often depend on where the tumor is located. The most common symptoms include:
EHE treatment depends on the location of the tumor and how severe it is.
A common treatment for EHE is surgery. During surgery, the surgeon removes the tumor and a small amount of tissue around the tumor. The healthy tissue that is removed is called a margin. Removing a margin of tissue makes sure the surgeon removes the whole tumor.
The care team may also use radiation, chemotherapy, or targeted therapies to treat EHE.
A person with EHE in the liver may receive a liver transplant.
In some cases, if the tumor spreads slowly, your child’s care team may take a wait-and-see approach. They monitor the tumor’s growth. This prevents your child from having treatments that are not needed or that may be harmful.
Survival rates for EHE are not well known. Rates depend on the tumor location and type of treatment:
St. Jude provides the highest quality of care for patients with EHE:
More reasons to choose St. Jude for care include:
St. Jude offers clinical trials and cancer research studies for children, teens, and young adults for EHE.
Study goal:
The purpose of this clinical trial is to find better treatments for NRSTS patients who are intermediate- and high-risk. Our goal is to lower the risk of the tumor coming back after treatment, while using treatments with fewer risks of long-term side effects.
Age:
Up to 30 years old.
Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334
The solid tumor coordinator is dedicated to helping you seek treatment or refer a patient.
Solid Tumor Coordinator